Also trades as: 0YAY.L (LSE) · $vol 1M · VTRLY (OTC) · $vol 0M

kr 91.80 ($9.14)

-1.05 (-1.13%)

Weekly Expected Move ±3.0%

kr 86 kr 89 kr 92 kr 95 kr 97

STO · Healthcare · Medical - Devices · Tech Score Neutral · Power 52 · kr 12.4B mcap · 74M float · 0.344% daily turnover

Revenue

$3.4B -4.7% ▼

5Y CAGR: +22.5%

Gross Profit

$1.8B -18.2% ▼

5Y CAGR: +17.9%

Operating Income

$616M -21.3% ▼

5Y CAGR: +10.7%

Net Income

-$5.0B -1077.2% ▼

EPS (Diluted)

$-37.01 -1079.1% ▼

EBITDA

-$4.4B -663.0% ▼

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.7B	$3.2B	$3.5B	$3.6B	$3.4B
YoY Growth	+34.9%	+92.4%	+8.6%	+2.8%	-4.7%
Cost of Revenue	$635M	$1.5B	$1.5B	$1.5B	$1.7B
Gross Profit	$1.0B	$1.8B	$2.0B	$2.1B	$1.8B
Gross Margin	62.2%	55.0%	56.3%	59.3%	50.9%
R&D Expenses	$114M	$143M	$228M	$117M	$111M
SG&A Expenses	$504M	$1.0B	$1.1B	$1.2B	$1.0B
Operating Expenses	$620M	$1.1B	$5.6B	$1.4B	$1.1B
Operating Income	$435M	$654M	-$3.6B	$783M	$616M
Operating Margin	25.9%	20.2%	-102.2%	21.7%	17.9%
Interest Expense	$10M	$60M	$102M	$109M	$51M
Income Before Tax	$460M	$537M	-$3.7B	$674M	-$4.9B
Tax Expense	$116M	$143M	$139M	$160M	$127M
Net Income	$341M	$394M	-$3.9B	$513M	-$5.0B
Net Margin	20.3%	12.2%	-109.7%	14.2%	-145.7%
EPS (Diluted)	$2.97	$2.91	$-28.44	$3.78	$-37.01
EBITDA	$580M	$977M	-$3.2B	$783M	-$4.4B
Shares Outstanding	115M	135M	135M	136M	135M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$867M	$959M	$842M	$871M	$835M	$891M	$807M	$857M
Cost of Revenue	$359M	$373M	$359M	$366M	$409M	$556M	$324M	$340M
Gross Profit	$508M	$586M	$483M	$505M	$426M	$336M	$483M	$517M
Gross Margin	58.6%	61.1%	57.4%	58.0%	51.0%	37.7%	59.9%	60.3%
R&D Expenses	$30M	$28M	$26M	$29M	$23M	$34M	$32M	$30M
SG&A Expenses	$290M	$341M	$298M	$333M	$248M	$377M	$251M	$239M
Operating Expenses	$334M	$361M	$332M	$368M	$271M	$163M	$334M	$319M
Operating Income	$174M	$225M	$151M	$137M	$155M	$173M	$149M	$198M
Operating Margin	20.1%	23.5%	17.9%	15.7%	18.6%	19.4%	18.5%	23.1%
Interest Expense	$18M	$43M	$10M	$5M	$13M	$23M	$20M	$0
Income Before Tax	$156M	$182M	$141M	$132M	$131M	-$5.3B	$130M	$179M
Tax Expense	$40M	$43M	$41M	$32M	$29M	$24M	$29M	$50M
Net Income	$116M	$139M	$100M	$100M	$102M	-$5.3B	$101M	$129M
Net Margin	13.4%	14.5%	11.9%	11.5%	12.2%	-596.4%	12.5%	15.1%
EPS (Diluted)	$0.86	$1.02	$0.74	$0.74	$0.75	$-39.24	$0.74	$0.95
EBITDA	$288M	$225M	$256M	$137M	$255M	-$5.2B	$209M	$258M
Shares Outstanding	136M	136M	135M	135M	135M	135M	135M	135M

VITR.ST STO